These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 35761158)

  • 1. Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study.
    Beau-Lejdstrom R; Hong LS; Garcia de Albeniz X; Floricel F; Lorenzen J; Bonfitto F; Kalilani L; Loesch C; Luscombe G; Perez-Gutthann S; Mottet I; Foskett N
    Drug Saf; 2022 Jul; 45(7):781-790. PubMed ID: 35761158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of levetiracetam and oxcarbazepine on 4-year fragility fracture risk among prepubertal and pubertal children with epilepsy.
    Whitney DG; Caird MS; Hurvitz EA; Rajapakse CS; Fedak Romanowski EM
    Epilepsia; 2021 Sep; 62(9):2180-2189. PubMed ID: 34250606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
    Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
    Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting.
    Welton J; Stratton G; Schoeninger B; Low MH; Moody A; D'Souza W
    Epilepsy Behav; 2023 Apr; 141():109145. PubMed ID: 36913876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
    Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
    Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database.
    Chen S; Fukasawa T; Ikeda A; Takeuchi M; Shimotake A; Yoshida S; Kawakami K
    Heliyon; 2023 Apr; 9(4):e15017. PubMed ID: 37064469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.
    Alsfouk BAA; Brodie MJ; Walters M; Kwan P; Chen Z
    JAMA Neurol; 2020 May; 77(5):574-581. PubMed ID: 32091535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan.
    Chiang KL; Liang CY; Hsieh LP; Chien LN
    Seizure; 2021 Dec; 93():145-153. PubMed ID: 34768177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental outcomes in children exposed prenatally to levetiracetam.
    Alsfouk BA
    Ther Adv Drug Saf; 2022; 13():20420986221088419. PubMed ID: 35387387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW; Youngerman BE; Choi H; Burke JF
    Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric adverse reactions to antiseizure medications - An analysis of data from the Italian spontaneous reporting system (2001-2019).
    Franco V; Barbieri MA; Cutroneo PM; Arena I; Cicala G; Marchione P; Spina E; Perucca E
    Epilepsy Behav; 2021 Jun; 119():107989. PubMed ID: 33946010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
    Privitera M; Richy FF; Schabert VF
    Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Long-Term Outcomes of Monotherapy and Polytherapy in Seizure-Free Patients With Epilepsy Following Antiseizure Medication Withdrawal.
    Wang Y; Xia L; Li R; Li Y; Li J; Zhou Q; Pan S
    Front Neurol; 2021; 12():669703. PubMed ID: 34108931
    [No Abstract]   [Full Text] [Related]  

  • 16. Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis.
    Fang T; Valdes E; Frontera JA
    Neurocrit Care; 2022 Feb; 36(1):248-258. PubMed ID: 34286461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
    Knight R; Wittkowski A; Bromley RL
    Epilepsia; 2021 Aug; 62(8):1765-1779. PubMed ID: 34128227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the use of antiseizure medications in children and adolescents in Norway, 2009-2018.
    Heger K; Skipsfjord J; Kiselev Y; Burns ML; Aaberg KM; Johannessen SI; Skurtveit S; Johannessen Landmark C
    Epilepsy Res; 2022 Mar; 181():106872. PubMed ID: 35180640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between antiseizure medications and quality of life in epilepsy: A mediation analysis.
    Wang M; Perera K; Josephson CB; Lamidi M; Lawal OA; Awosoga O; Roach P; Patten SB; Wiebe S; Sajobi TT
    Epilepsia; 2022 Feb; 63(2):440-450. PubMed ID: 34931300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Prescribing of Antiseizure Medications in South Korea: Real-World Evidence for Treated Patients With Epilepsy.
    Kang KW; Lee H; Shin JY; Moon HJ; Lee SY
    J Clin Neurol; 2022 Mar; 18(2):179-193. PubMed ID: 35274836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.